Clinical trials
Phase 1/2 Cardiovascular Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2008 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 4 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 4D Molecular Therapeutics | 1 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Atavistik Bio, Inc | 1 |
| Baylor College of Medicine | 1 |
| Celladon Corporation | 1 |
| Colorado State University | 1 |
| Helios Cardio Inc. | 1 |
| Indiana University | 1 |
| Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 1 |
| Lacy Alexander | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 28 |
| Heart Diseases | 6 |
| Hypertension | 6 |
| Vascular Diseases | 4 |
| Atherosclerosis | 3 |
| Heart Failure | 3 |
| Cardiomyopathies | 2 |
| Central Nervous System Diseases | 2 |
| Disease | 2 |
| Essential Hypertension | 2 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.